Ebusco Holding NV
F:8J30
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ebusco Holding NV
F:8J30
|
NL |
|
O
|
OHB SE
XHAM:OHB
|
DE |
|
A
|
Allergy Therapeutics PLC
XBER:HHU
|
UK |
|
Hertz Global Holdings Inc
F:AZK0
|
US |
|
Atex Resources Inc
TSX:ATX
|
CA |
|
Dovalue SpA
F:1DB0
|
IT |
|
I
|
IPH Ltd
OTC:IPHLF
|
AU |
|
P
|
Peugeot Invest SA
XMUN:FFP
|
FR |
|
S
|
Safehold Inc
F:2T3
|
US |
|
O
|
Organon & Co
F:7XP
|
US |
|
P
|
PG&E Corp
F:PCG
|
US |
|
Amerisafe Inc
NASDAQ:AMSF
|
US |
Wall St Price Targets
8J30 Price Targets Summary
Ebusco Holding NV
According to Wall Street analysts, the average 1-year price target for
8J30 is 0.7711 EUR with a low forecast of 0.7636 EUR and a high forecast of 0.7938 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8J30's stock price target?
Price Target
0.7711
EUR
According to Wall Street analysts, the average 1-year price target for
8J30 is 0.7711 EUR with a low forecast of 0.7636 EUR and a high forecast of 0.7938 EUR.
What is the Revenue forecast for Ebusco Holding NV?
Projected CAGR
513%
Over the last 5 years, the compound annual growth rate for Revenue has been -26%. The projected CAGR for the next 2 years is 513%.